ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

VYGR Company Profile and Key Details

NASDAQ : VYGR

Voyager Therapeutics, Inc.

$3.97

-0.2-4.80%

At Close 4:00 PM

66.71

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

VYGR Stock Price Chart

Stock Price Today

Voyager Therapeutics, Inc. (VYGR) stock declined over -4.80%, trading at $3.97 on NASDAQ, down from the previous close of $4.17. The stock opened at $4.15, fluctuating between $3.90 and $4.19 in the recent session.

Stock Snapshot

4.17

Prev. Close

4.15

Open

216.86M

Market Cap

54.63M

Number of Shares

3.895

Day Low

4.185

Day High

6.02

P/E Ratio

81.28%

Free Float in %

0.66

EPS (TTM)

5.37

Book Value

1.65

Cash Flow per Share

560.94K

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Mar 11, 2025	4.15	4.18	3.89	3.97	548.87K
Mar 10, 2025	4.21	4.31	4.12	4.16	258.36K
Mar 07, 2025	4.12	4.32	4.06	4.26	425.79K
Mar 06, 2025	4.10	4.18	4.04	4.14	234.01K
Mar 05, 2025	3.99	4.16	3.97	4.15	287.1K
Mar 04, 2025	3.88	4.00	3.80	3.96	408.8K
Mar 03, 2025	4.13	4.13	3.88	3.91	383.91K
Feb 28, 2025	4.00	4.08	3.91	4.08	264.97K
Feb 27, 2025	4.13	4.13	4.00	4.01	245.91K
Feb 26, 2025	4.12	4.19	4.06	4.13	243.8K
Feb 25, 2025	4.13	4.20	4.03	4.12	247.61K
Feb 24, 2025	4.21	4.22	4.08	4.10	279.73K
Feb 21, 2025	4.29	4.35	4.21	4.22	282.62K
Feb 20, 2025	4.36	4.39	4.21	4.26	312.4K
Feb 19, 2025	4.31	4.42	4.22	4.30	256.23K
Feb 18, 2025	4.26	4.53	4.23	4.31	411.31K
Feb 14, 2025	4.38	4.60	4.20	4.23	442.1K
Feb 13, 2025	4.43	4.52	4.32	4.38	391.79K
Feb 12, 2025	4.24	4.44	4.00	4.42	762.06K
Feb 11, 2025	5.16	5.20	4.13	4.21	1.39M

Contact Details

Cambridge, MA 02139

United States

Website: https://www.voyagertherapeutics.comContact: 857 259 5340

About Company

Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyotrophic lateral sclerosis; VY-HTT01 for Huntington's disease; VY-FXN01 for Friedreich's ataxia; and Tau program for the treatment of tauopathies, including Alzheimer's disease, progressive supranuclear palsy, and frontotemporal dementia, as well as for spinal muscular atrophy. The company has collaboration and license agreements with Neurocrine Biosciences, Inc., Pfizer Inc., and Novartis Pharma, A.G. for the research, development, and commercialization of adeno-associated virus gene therapy products. Voyager Therapeutics, Inc. was incorporated in 2013 and is headquartered in Cambridge, Massachusetts.

Frequently Asked Questions

What is the current Voyager Therapeutics, Inc. (VYGR) stock price?

Voyager Therapeutics, Inc. (NASDAQ: VYGR) stock price is $3.97 in the last trading session. During the trading session, VYGR stock reached the peak price of $4.19 while $3.90 was the lowest point it dropped to. The percentage change in VYGR stock occurred in the recent session was -4.8% while the dollar amount for the price change in VYGR stock was -$0.20.

VYGR's industry and sector of operation?

The NASDAQ listed VYGR is part of Biotechnology industry that operates in the broader Healthcare sector. Voyager Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of VYGR?

Mr. Todd Carter Ph.D.
Chief Science Officer
Dr. Mark A. Kay M.D., Ph.D.
Founder
Mr. Peter P. Pfreundschuh CPA
Chief Financial Officer
Dr. Phillip D. Zamore
Founder
Mr. Robert W. Hesslein
Senior Vice President & Gen. Counsel
Mr. G. Andre Turenne
Advisor
Dr. Alfred W. Sandrock Jr., M.D., Ph.D.
Pres, Chief Executive Officer & Director
Dr. Phillip D. Zamore Ph.D.
Founder & Member of Scientific Advisory Board
Dr. Krystof Bankiewicz M.D., Ph.D.
Founder
Ms. Robin Swartz
Chief Operating Officer
Ms. Michelle Quinn Smith
Chief HR Officer
Mr. Robert W. Hesslein Esq., J.D.
Senior Vice President & Gen. Counsel
Ms. Jacquelyn Fahey Sandell Esq., J.D.
Chief Legal Officer

How VYGR did perform over past 52-week?

VYGR's closing price is 4.47% higher than its 52-week low of $3.80 where as its distance from 52-week high of $10.66 is -62.76%.

How many employees does VYGR have?

Number of VYGR employees currently stands at 162.

Link for VYGR official website?

Official Website of VYGR is: https://www.voyagertherapeutics.com

How do I contact VYGR?

VYGR could be contacted at phone 857 259 5340 and can also be accessed through its website. VYGR operates from 75 Sidney Street, Cambridge, MA 02139, United States.

How many shares of VYGR are traded daily?

VYGR stock volume for the day was 560.94K shares. The average number of VYGR shares traded daily for last 3 months was 366.67K.

What is the market cap of VYGR currently?

The market value of VYGR currently stands at $216.86M with its latest stock price at $3.97 and 54.63M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

Employees	162
Beta	0.99
Sales or Revenue	$250.01M
5Y Sales Change%	23.458%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology